Verapamil HCl 15% Transdermal Cream is a semisolid preparation intended for topical application. This cream is dispensed in a pump mechanism, which allows for convenient and controlled dosing. The formulation is designed to facilitate the localized treatment of conditions such as Peyronie's disease and plantar fibromatosis. By applying the cream directly to the affected area, the active ingredient, Verapamil HCl, works to reduce collagen overproduction and fibrous tissue buildup. This transdermal delivery system ensures that the medication is absorbed into the skin, targeting the site of pathology while minimizing systemic exposure.
Verapamil HCl 15% Transdermal Cream is a specially compounded medication designed to deliver the calcium channel blocker Verapamil through the skin. This semisolid preparation is dispensed in a pump mechanism, which allows for convenient, controlled, and consistent application. The cream is intended for localized treatment, providing a targeted approach that may reduce systemic side effects commonly associated with oral administration of Verapamil. The transdermal delivery system is particularly beneficial for patients who may have difficulties with oral dosing or for those who require a steady release of medication over an extended period.
Verapamil is primarily known for its ability to treat cardiovascular conditions by inhibiting the influx of calcium ions into cardiac muscle and vascular smooth muscle cells. This action leads to a decrease in cardiac contractility, a reduction in heart rate, and dilation of the arteries, which can lower blood pressure. While Verapamil is traditionally used to manage hypertension, angina, and certain cardiac arrhythmias, its use in a transdermal cream form allows for the exploration of other therapeutic applications. For instance, Verapamil has been studied for the treatment of Peyronie's disease, where it may help reduce the curvature and associated pain by disrupting the production of collagen and fibrous tissues. Additionally, it has been used off-label for the treatment of plantar fibromatosis and other localized fibrotic conditions.
Patients and prescribers should be aware that the efficacy and safety of Verapamil HCl 15% Transdermal Cream for these indications may vary and that clinical studies are still ongoing to fully establish its therapeutic potential in these disease states. It is important to apply the cream as directed by a healthcare professional and to understand that response to treatment can be individualized. Regular monitoring and follow-up with the prescribing physician are essential to ensure optimal outcomes and to manage any potential side effects.
For those interested in using Verapamil HCl 15% Transdermal Cream, or for healthcare providers considering it for their patients, please reach out to us at Bayview Pharmacy for more detailed information. Our team of compounding pharmacists is equipped to answer questions, provide guidance on appropriate use, and discuss the potential benefits and limitations of this formulation. We are committed to supporting our patients and the medical community with high-quality, customized medication solutions.
Verapamil HCl is a calcium channel blocker that is commonly used to treat high blood pressure, angina, and certain heart rhythm disorders when taken orally. As a 15% transdermal cream, it may be used for localized treatment, potentially reducing systemic side effects. However, even when applied topically, verapamil can be absorbed into the bloodstream and may interact with other medications. It is important for both patients and prescribers to be aware of these potential interactions.
Verapamil can interact with drugs that affect heart rhythm, such as beta-blockers (e.g., metoprolol, atenolol), digoxin, and amiodarone. Combining these medications with verapamil may increase the risk of bradycardia, heart block, or other cardiac conduction abnormalities. Patients should be monitored closely for symptoms of excessive cardiac suppression.
Concomitant use of verapamil with drugs that are substrates of the cytochrome P450 3A4 (CYP3A4) enzyme can result in altered drug levels. Verapamil is a known inhibitor of CYP3A4, and can increase the plasma concentrations of medications metabolized by this pathway, such as statins (e.g., simvastatin, atorvastatin), certain antifungal agents (e.g., ketoconazole, itraconazole), and some antiretroviral drugs. This may lead to an increased risk of side effects associated with these medications.
Patients taking immunosuppressants like cyclosporine or tacrolimus should be cautious, as verapamil can increase their blood levels, potentially leading to toxicity. Blood levels of these drugs should be monitored, and dosage adjustments may be necessary.
Verapamil may also interact with other blood pressure medications, leading to an additive hypotensive effect. This can result in symptoms such as dizziness, lightheadedness, or fainting. Patients should be advised to monitor their blood pressure regularly and report any significant changes to their healthcare provider.
Grapefruit juice can increase the systemic absorption of verapamil, potentially leading to increased effects or adverse reactions. Patients should be advised to avoid grapefruit and grapefruit juice while using verapamil transdermal cream.
It is also important to note that the transdermal route bypasses the first-pass metabolism, which may result in different pharmacokinetic properties compared to oral administration. Therefore, the potential for drug interactions may differ from those typically expected with oral verapamil.
Before using verapamil transdermal cream, patients should inform their healthcare provider of all medications they are taking, including prescription, over-the-counter, herbal supplements, and vitamins to assess for potential drug interactions. If you have any questions or concerns regarding the use of Verapamil HCl 15% Transdermal Cream and its interactions with other drugs, please reach out to us at Bayview Pharmacy for further assistance.
Verapamil HCl 15% Transdermal Cream is a specially formulated medication that is designed to deliver the active ingredient, Verapamil Hydrochloride, directly through the skin. Verapamil is a calcium channel blocker that works by inhibiting the influx of calcium ions into cardiac muscle and smooth muscle without changing serum calcium concentrations. This action results in the dilation of the coronary and systemic arteries, leading to decreased blood pressure and reduced cardiac workload.
In this transdermal form, Verapamil HCl is incorporated into a cream base that allows for the drug to be absorbed through the skin. The cream is designed to release the medication in a controlled manner, ensuring a consistent therapeutic effect. The semisolid preparation is dispensed in a pump mechanism, which provides a convenient and hygienic method of application while also allowing for precise dosing. Patients are able to apply the cream to the affected area, ensuring that the medication is localized, which can reduce systemic side effects compared to oral administration.
Transdermal delivery of Verapamil is particularly useful for the treatment of conditions such as Peyronie's disease, where the medication can help to reduce the curvature and discomfort associated with this condition. It is also used off-label for the management of plantar fibromatosis, where the anti-fibrotic properties of Verapamil may help to reduce the size of fibrous plaques that cause pain and discomfort in the feet. Additionally, the transdermal route avoids first-pass metabolism by the liver, potentially reducing the risk of hepatic side effects and allowing for more of the drug to reach the target tissues.
It is important for patients and prescribers to understand that while transdermal delivery systems offer many advantages, they also require proper application to ensure effectiveness. The skin should be clean and intact before application, and the cream should be applied as directed, typically in a thin layer over the affected area. Patients should be advised not to cover the treated area with occlusive dressings unless directed by a healthcare provider, as this may alter the absorption of the medication.
For more detailed information on Verapamil HCl 15% Transdermal Cream, its pharmacokinetics, specific usage instructions, potential side effects, and contraindications, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the necessary support and guidance to ensure safe and effective treatment for your patients.
Verapamil HCl 15% Transdermal Cream has been traditionally used to deliver its active ingredient through the skin, working for the localized treatment of conditions such as plantar fibromatosis (Ledderhose's disease) and Peyronie's disease. However, its applications are not limited to these specific diseases states. The antispasmodic and vasodilatory properties of verapamil make this cream potentially useful for off-label purposes, such as the treatment of certain types of localized muscle spasms where cutaneous penetration of the medication might provide relief. It has been considered for use in cases of superficial vasospasm, like Raynaud's phenomenon, by some practitioners, although high-quality evidence supporting this use is limited. Furthermore, anecdotal evidence has suggested potential utility in localized neuropathic pain conditions where calcium channel blockers like verapamil could modulate pain signals.
Nonetheless, it is important to approach such alternative uses with caution and under the supervision of a healthcare professional, as the systemic absorption of verapamil through the skin could lead to systemic effects. While the design of the transdermal cream in a pump mechanism allows for controlled dosing, patients and prescribers should still consider the potential for systemic exposure, interactions with systemic medications, and contraindications that are applicable to oral or intravenous verapamil. Adjustments in dosing or monitoring may be necessary depending on the patient's overall medication regimen and health profile.
This preparation could also be used in clinical studies exploring the transdermal delivery of verapamil for other medical conditions where this route might offer advantages over oral administration, including potentially reduced gastrointestinal side effects or improved compliance. Healthcare professionals who are considering this formulation for novel purposes should do so in the context of evidence-based practice, clinical expertise, and in accordance with regulatory guidelines related to the use of compounded medications for non-approved indications. We at Bayview Pharmacy are dedicated to providing high-quality compounded medications and information. Should you have any questions regarding the potential uses of Verapamil HCl 15% Transdermal Cream, or if you would like to discuss specific patient needs, please do not hesitate to reach out to us. Our team is ready to support you with the necessary guidance for making informed decisions about the use of our formulations.
Verapamil HCl 15% Transdermal Cream is a topical medication that contains Verapamil Hydrochloride at a concentration of 15%. It is used to deliver the active ingredient through the skin for localized treatment or systemic absorption.
This medication should be stored in a cool, dry place, away from direct sunlight and heat. Keep the cream at room temperature and out of reach of children and pets. Always check the expiration date before use.
The cream is dispensed in a pump mechanism, which allows for convenient and controlled application. This packaging helps to ensure proper dosage and to minimise contamination of the product.
Verapamil HCl Transdermal Cream is typically used for the localized treatment of conditions where Verapamil may provide therapeutic benefits, such as certain types of chronic pain. Always use this medication as directed by your healthcare provider.
Clean and dry the affected area first. Press the pump to dispense a small amount of cream onto your fingertips or directly onto the skin, and gently rub in using a circular motion until fully absorbed. Follow the dosage instructions provided by your pharmacist or healthcare provider. Do not cover with a bandage unless advised.
Always inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and supplements, as there can be interactions. Your healthcare provider will advise you on the safety of using Verapamil HCl Transdermal Cream with other medications.
If you miss a dose, apply the dose as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double up to make up for a missed dose.
Side effects can include local skin irritation, redness, or itching. Systemic side effects are less common with transdermal applications but may still occur. Notify your healthcare provider if you experience any unusual symptoms.
The safety of Verapamil HCl Transdermal Cream during pregnancy or breastfeeding has not been fully established. Always consult your healthcare provider for advice before using any medication in these circumstances.
It’s typically recommended to wait at least one hour before applying other topical products like moisturizers over the same area to ensure that Verapamil HCl Transdermal Cream has been adequately absorbed. Consult with your healthcare provider for personalized advice.
An overdose of Verapamil HCl Transdermal Cream is unlikely when used as directed, but if you suspect an overdose or experience severe adverse reactions, seek medical attention immediately. It is important to only use the dosage prescribed by your healthcare provider.